HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Anderson Ryan Selected Research
Anderson Ryan Research Topics
Disease
20
Neoplasms (Cancer)
01/2022 - 12/2004
5
Lung Neoplasms (Lung Cancer)
01/2021 - 11/2005
4
Neoplasm Metastasis (Metastasis)
03/2012 - 01/2004
3
Carcinoma (Carcinomatosis)
09/2009 - 05/2005
2
Adenocarcinoma of Lung
01/2019 - 12/2007
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2012 - 12/2007
2
Colorectal Neoplasms (Colorectal Cancer)
07/2010 - 11/2009
2
Pleural Effusion (Pleural Effusions)
06/2008 - 12/2007
2
Colonic Neoplasms (Colon Cancer)
11/2005 - 12/2004
2
Glioblastoma (Glioblastoma Multiforme)
08/2005 - 01/2005
1
Bites and Stings (Sting)
01/2022
1
Alcoholism (Alcohol Abuse)
10/2017
1
Hypersensitivity (Allergy)
10/2017
1
Renal Cell Carcinoma (Grawitz Tumor)
12/2009
1
Hepatocellular Carcinoma (Hepatoma)
09/2009
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
09/2009
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2009
1
Breast Neoplasms (Breast Cancer)
08/2008
1
Malignant Mesothelioma
06/2008
1
Neuroblastoma
02/2008
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2005
1
Neoplasm Micrometastasis
12/2005
1
Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
05/2005
1
Multiple Endocrine Neoplasia Type 2a (MEN 2)
05/2005
1
Multiple Endocrine Neoplasia Type 2b (MEN 3)
05/2005
1
Lewis Lung Carcinoma
05/2005
1
Papillary Thyroid Cancer
05/2005
1
Hypoxia (Hypoxemia)
01/2005
1
Necrosis
01/2005
1
Pancreatic Neoplasms (Pancreatic Cancer)
12/2004
Drug/Important Bio-Agent (IBA)
12
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2012 - 05/2005
10
vandetanib (ZD6474)
IBA
11/2009 - 01/2004
8
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
03/2012 - 08/2005
6
Phosphotransferases (Kinase)
IBA
03/2012 - 05/2005
4
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
07/2010 - 08/2005
4
ErbB Receptors (EGF Receptor)
IBA
08/2008 - 08/2005
3
Tyrosine (L-Tyrosine)
FDA Link
03/2012 - 12/2005
3
cediranib (AZD2171)
IBA
03/2012 - 09/2009
3
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
09/2009 - 08/2005
2
Pharmaceutical Preparations
IBA
01/2022 - 01/2021
2
Biomarkers (Surrogate Marker)
IBA
01/2019 - 12/2009
2
Proteins (Proteins, Gene)
FDA Link
03/2012 - 08/2005
2
Vascular Endothelial Growth Factor Receptor-3 (Flt 4)
IBA
07/2010 - 09/2009
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
11/2009 - 05/2005
2
Tyrosine Kinase Inhibitors
IBA
06/2009 - 02/2008
2
Epidermal Growth Factor (EGF)
IBA
12/2007 - 12/2005
2
N-acetylcochinol-O-phosphate
IBA
01/2005 - 01/2004
1
lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)
IBA
01/2022
1
pyridostatin
IBA
01/2022
1
DNA (Deoxyribonucleic Acid)
IBA
01/2022
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2022
1
Single-Stranded DNA (DNA, Single Stranded)
IBA
01/2021
1
Protein Kinases (Protein Kinase)
IBA
01/2021
1
Collagen
IBA
01/2019
1
Prolyl Hydroxylases (Prolyl Hydroxylase)
IBA
01/2019
1
Acetaldehyde
IBA
10/2017
1
Disulfiram (Antabuse)
FDA Link
10/2017
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
10/2017
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
10/2017
1
AZD 6244
IBA
03/2012
1
MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)
IBA
03/2012
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
03/2012
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
03/2012
1
Mitogens
IBA
03/2012
1
Antibodies
IBA
07/2010
1
Biological Products
IBA
12/2009
1
Phosphates (Orthophosphate)
IBA
11/2009
1
Irinotecan (Camptosar)
FDA Link
Generic
11/2009
1
Vascular Endothelial Growth Factors
IBA
09/2009
1
Ligands
IBA
09/2009
1
Bevacizumab (Avastin)
FDA Link
02/2008
1
Proto-Oncogene Proteins c-ret
IBA
02/2008
1
Monoclonal Antibodies
IBA
02/2008
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
02/2008
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
02/2008
1
Mitogen-Activated Protein Kinases
IBA
02/2008
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
12/2007
1
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
12/2007
1
A-factor (Streptomyces)
IBA
12/2007
1
Integrins
IBA
11/2005
1
Protein Isoforms (Isoforms)
IBA
05/2005
1
Angiogenesis Inhibitors
IBA
05/2005
1
Nitric Oxide Synthase (NO Synthase)
IBA
01/2005
1
Oxygen (Dioxygen)
IBA
01/2005
1
Gemcitabine
FDA Link
12/2004
1
AZM475271
IBA
12/2004
1
src-Family Kinases
IBA
12/2004
Therapy/Procedure
6
Therapeutics
07/2010 - 11/2005
5
Radiotherapy
11/2009 - 01/2005
2
Drug Therapy (Chemotherapy)
01/2022 - 08/2005
2
Aftercare (After-Treatment)
02/2008 - 11/2005
1
Chemoradiotherapy
12/2007
1
Withholding Treatment
08/2005
1
Oral Administration
12/2004